189 related articles for article (PubMed ID: 26854363)
1. Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents.
Ribed A; Escudero-Vilaplana V; Romero-Jimenez RM; Iglesias-Peinado I; Herranz-Alonso A; Sanjurjo-Saez M
Expert Opin Drug Saf; 2016; 15(4):427-35. PubMed ID: 26854363
[TBL] [Abstract][Full Text] [Related]
2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
[TBL] [Abstract][Full Text] [Related]
4. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
5. Impact of a transition-of-care pharmacist during hospital discharge.
Balling L; Erstad BL; Weibel K
J Am Pharm Assoc (2003); 2015; 55(4):443-8. PubMed ID: 26161488
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective.
Marzal-Alfaro MB; Escudero-Vilaplana V; Revuelta-Herrero JL; Collado-Borrell R; Herranz-Alonso A; Sanjurjo-Saez M
Front Oncol; 2021; 11():636068. PubMed ID: 33777790
[TBL] [Abstract][Full Text] [Related]
8. EPICC study: evaluation of pharmaceutical intervention in cancer care.
Vantard N; Ranchon F; Schwiertz V; Gourc C; Gauthier N; Guedat MG; He S; Kiouris E; Alloux C; You B; Souquet PJ; Freyer G; Salles G; Trillet-Lenoir V; Rioufol C
J Clin Pharm Ther; 2015 Apr; 40(2):196-203. PubMed ID: 25594148
[TBL] [Abstract][Full Text] [Related]
9. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
10. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
Kuo GM; Touchette DR; Marinac JS
Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
[TBL] [Abstract][Full Text] [Related]
11. Safety considerations and safe handling of oral chemotherapy agents.
Griffin E
Clin J Oncol Nurs; 2003; 7(6 Suppl):25-9. PubMed ID: 14705497
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' perceived knowledge of and confidence in dispensing oral antineoplastic agents.
Dayer L; Dunn E; Pace A; Flowers S
J Am Pharm Assoc (2003); 2016; 56(2):141-4.e2. PubMed ID: 27000164
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary Optimization of Oral Chemotherapy Delivery at the University of Wisconsin Carbone Cancer Center.
Mulkerin DL; Bergsbaken JJ; Fischer JA; Mulkerin MJ; Bohler AM; Mably MS
J Oncol Pract; 2016 Oct; 12(10):e912-e923. PubMed ID: 27858570
[TBL] [Abstract][Full Text] [Related]
14. Adverse effect monitoring: opportunity for patient care and pharmacy practice.
Hermansen-Kobulnicky CJ; Wiederholt JB; Chewning B
J Am Pharm Assoc (2003); 2004; 44(1):75-86; quiz 87-8. PubMed ID: 14965157
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist-managed oral anticoagulation therapy in the community setting.
Bouwmeester C; Chim C
Consult Pharm; 2013 May; 28(5):280-94. PubMed ID: 23649677
[TBL] [Abstract][Full Text] [Related]
16. [Improving medication safety].
Grandt D
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Dec; 52(12):1161-5. PubMed ID: 19862485
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center.
Solomon JM; Ajewole VB; Schneider AM; Sharma M; Bernicker EH
J Oncol Pharm Pract; 2019 Oct; 25(7):1564-1569. PubMed ID: 30170514
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
Milfred-Laforest SK; Chow SL; Didomenico RJ; Dracup K; Ensor CR; Gattis-Stough W; Heywood JT; Lindenfeld J; Page RL; Patterson JH; Vardeny O; Massie BM
J Card Fail; 2013 May; 19(5):354-69. PubMed ID: 23663818
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
Snider M; Kalbfleisch S; Carnes CA
Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
[TBL] [Abstract][Full Text] [Related]
20. The oral education clinic: A pharmacist- and nurse-led clinic to support patients starting oral systemic anti-cancer treatments.
Mawhinney MW; Warden J; Stoner N
J Oncol Pharm Pract; 2019 Mar; 25(2):449-453. PubMed ID: 28841100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
